BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 21484785)

  • 1. Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis.
    Freigang S; Ampenberger F; Spohn G; Heer S; Shamshiev AT; Kisielow J; Hersberger M; Yamamoto M; Bachmann MF; Kopf M
    Eur J Immunol; 2011 Jul; 41(7):2040-51. PubMed ID: 21484785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
    van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
    Duewell P; Kono H; Rayner KJ; Sirois CM; Vladimer G; Bauernfeind FG; Abela GS; Franchi L; Nuñez G; Schnurr M; Espevik T; Lien E; Fitzgerald KA; Rock KL; Moore KJ; Wright SD; Hornung V; Latz E
    Nature; 2010 Apr; 464(7293):1357-61. PubMed ID: 20428172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
    Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
    Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis.
    Rajamäki K; Mäyränpää MI; Risco A; Tuimala J; Nurmi K; Cuenda A; Eklund KK; Öörni K; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1937-46. PubMed ID: 27417584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.
    Usui F; Shirasuna K; Kimura H; Tatsumi K; Kawashima A; Karasawa T; Yoshimura K; Aoki H; Tsutsui H; Noda T; Sagara J; Taniguchi S; Takahashi M
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):127-36. PubMed ID: 25378412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
    Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
    Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cereal Fiber Ameliorates High-Fat/Cholesterol-Diet-Induced Atherosclerosis by Modulating the NLRP3 Inflammasome Pathway in ApoE
    Zhang R; Han S; Zhang Z; Zhang W; Yang J; Wan Z; Qin L
    J Agric Food Chem; 2018 May; 66(19):4827-4834. PubMed ID: 29664631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
    Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
    J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
    Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
    Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
    Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
    Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFAT5 mediates hypertonic stress-induced atherosclerosis via activating NLRP3 inflammasome in endothelium.
    Ma P; Zha S; Shen X; Zhao Y; Li L; Yang L; Lei M; Liu W
    Cell Commun Signal; 2019 Aug; 17(1):102. PubMed ID: 31429763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury.
    Hou Y; Wang Y; He Q; Li L; Xie H; Zhao Y; Zhao J
    Behav Brain Res; 2018 Jan; 336():32-39. PubMed ID: 28851669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation.
    Peng K; Liu L; Wei D; Lv Y; Wang G; Xiong W; Wang X; Altaf A; Wang L; He D; Wang H; Qu P
    Int J Mol Med; 2015 May; 35(5):1179-88. PubMed ID: 25761252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming.
    Liu X; Zhang X; Ding Y; Zhou W; Tao L; Lu P; Wang Y; Hu R
    Antioxid Redox Signal; 2017 Jan; 26(1):28-43. PubMed ID: 27308893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis.
    Shi X; Xie WL; Kong WW; Chen D; Qu P
    J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2455-66. PubMed ID: 26381780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor E2-related factor-2 (Nrf2) is required for NLRP3 and AIM2 inflammasome activation.
    Zhao C; Gillette DD; Li X; Zhang Z; Wen H
    J Biol Chem; 2014 Jun; 289(24):17020-9. PubMed ID: 24798340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
    Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
    J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in mice.
    Bode N; Grebe A; Kerksiek A; Lütjohann D; Werner N; Nickenig G; Latz E; Zimmer S
    Biochem Biophys Res Commun; 2016 Sep; 478(1):356-362. PubMed ID: 27416761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells.
    Hu Q; Zhang T; Yi L; Zhou X; Mi M
    Biofactors; 2018 Mar; 44(2):123-136. PubMed ID: 29193391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.